Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000766506 | SCV000574015 | uncertain significance | not provided | 2017-03-22 | criteria provided, single submitter | clinical testing | The T1540I variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The T1540I variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The T1540I variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is not conserved, and in silico analysis predicts this variant likely does not alter the protein structure/function. In summary, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Genetic Services Laboratory, |
RCV000482310 | SCV000595110 | uncertain significance | not specified | 2016-07-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002526976 | SCV003277836 | likely benign | Methylmalonic acidemia with homocystinuria, type cblX | 2023-11-15 | criteria provided, single submitter | clinical testing |